127 related articles for article (PubMed ID: 38493476)
1. Ankrd26 is a retinoic acid-responsive plasma membrane-binding and -shaping protein critical for proper cell differentiation.
Englisch AS; Hofbrucker-MacKenzie SA; Izadi-Seitz M; Kessels MM; Qualmann B
Cell Rep; 2024 Mar; 43(3):113939. PubMed ID: 38493476
[TBL] [Abstract][Full Text] [Related]
2. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation.
Kauss MA; Reiterer G; Bunaciu RP; Yen A
Exp Cell Res; 2008 Oct; 314(16):2999-3006. PubMed ID: 18692045
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels.
Lamkin TJ; Chin V; Varvayanis S; Smith JL; Sramkoski RM; Jacobberger JW; Yen A
J Cell Biochem; 2006 Apr; 97(6):1328-38. PubMed ID: 16329108
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of hypoxia-inducible factor-1 alpha protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid.
Zhang J; Song LP; Huang Y; Zhao Q; Zhao KW; Chen GQ
Haematologica; 2008 Oct; 93(10):1480-7. PubMed ID: 18728026
[TBL] [Abstract][Full Text] [Related]
6. 5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia.
Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A
J Hematol Oncol; 2017 Jan; 10(1):18. PubMed ID: 28100250
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional corepressor CBFA2T3 inhibits all-
Steinauer N; Guo C; Zhang J
J Biol Chem; 2020 Jul; 295(27):8887-8900. PubMed ID: 32434928
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle.
Wightman J; Roberson MS; Lamkin TJ; Varvayanis S; Yen A
Mol Cancer Ther; 2002 May; 1(7):493-506. PubMed ID: 12479267
[TBL] [Abstract][Full Text] [Related]
9. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
Basso-Valentina F; Donada A; Manchev VT; Lisetto M; Balayn N; Martin JE; Muller D; Oyarzun CPM; Duparc H; Arkoun B; Cumin A; Faivre L; Droin N; Biunno I; Pecci A; Balduini A; Debili N; Antony-Debré I; Marty C; Vainchenker W; Plo I; Favier R; Raslova H
Haematologica; 2023 Aug; 108(8):2130-2145. PubMed ID: 36794499
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
Ruthardt M; Testa U; Nervi C; Ferrucci PF; Grignani F; Puccetti E; Grignani F; Peschle C; Pelicci PG
Mol Cell Biol; 1997 Aug; 17(8):4859-69. PubMed ID: 9234742
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid acylation (retinoylation) of a nuclear protein in the human acute myeloid leukemia cell line HL60.
Takahashi N; Breitman TR
J Biol Chem; 1989 Mar; 264(9):5159-63. PubMed ID: 2925686
[TBL] [Abstract][Full Text] [Related]
12. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
14. PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17).
Bullinger L; Schlenk RF; Götz M; Botzenhardt U; Hofmann S; Russ AC; Babiak A; Zhang L; Schneider V; Döhner K; Schmitt M; Döhner H; Greiner J
Clin Cancer Res; 2013 May; 19(9):2562-71. PubMed ID: 23444226
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
[TBL] [Abstract][Full Text] [Related]
16. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM.
Yin W; Rossin A; Clifford JL; Gronemeyer H
Oncogene; 2006 Jun; 25(26):3735-44. PubMed ID: 16449964
[TBL] [Abstract][Full Text] [Related]
17. GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines.
Jiang YZ; Hu LY; Chen MS; Wang XJ; Tan CN; Xue PP; Yu T; He XY; Xiang LX; Xiao YN; Li XL; Ran Q; Li ZJ; Chen L
World J Stem Cells; 2024 May; 16(5):538-550. PubMed ID: 38817334
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
19. CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells.
Si J; Mueller L; Collins SJ
J Clin Invest; 2007 May; 117(5):1412-21. PubMed ID: 17431504
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid affects the EGF-R signaling pathway during differentiation induction of human endometrial adenocarcinoma cells.
Carter CA; Shaw BL
Exp Mol Pathol; 2000 Jun; 68(3):170-86. PubMed ID: 10816385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]